Indianapolis, IN, United States of America

Phillip Edgar Pash

This inventor holds 17 USPTO granted patents and 6 published patent applications and 11 EPO patents. Top assignees: Roche Diagnostics Operations, Inc., Roche Diabetes Care, Inc., Roche Diagnostics International Ag. Active years: 1995-2023.

USPTO Granted Patents = 17 

% Patents Active = 94.1

 

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 342(Granted Patents)


Company Filing History:


Years Active: 1995-2023

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Phillip Edgar Pash

Introduction: Phillip Edgar Pash, a talented inventor hailing from Indianapolis, IN (US), has made significant contributions to the world of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Phillip Edgar Pash holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on cutting-edge advancements in renewable energy and sustainable living solutions.

Career Highlights: Throughout his illustrious career, Phillip Edgar Pash has been recognized for his groundbreaking inventions that have improved efficiency and sustainability across industries. His innovative spirit has led to the development of revolutionary products that have positively impacted society.

Collaborations: Phillip Edgar Pash has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible solutions that address real-world challenges.

Conclusion: In conclusion, Phillip Edgar Pash stands as a beacon of innovation in the field of inventions. His relentless pursuit of excellence and passion for creating a better future through his inventions make him a true pioneer in the world of innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…